The efficacy of antipsychotics for prolonged delirium with renal dysfunction

Satoko Asano, Yasuto Kunii, Hiroshi Hoshino, Yusuke Osakabe, Tetsuya Shiga, Shuntaro Itagaki, Itaru Miura, Hirooki Yabe Department of Neuropsychiatry, School of Medicine Fukushima Medical University, Fukushima, Japan Aim: Delirium is commonly encountered in daily clinical practice. To identify pre...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Asano S, Kunii Y, Hoshino H, Osakabe Y, Shiga T, Itagaki S, Miura I, Yabe H
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://doaj.org/article/9b916fb992424d63bb8cfa9ae0811270
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9b916fb992424d63bb8cfa9ae0811270
record_format dspace
spelling oai:doaj.org-article:9b916fb992424d63bb8cfa9ae08112702021-12-02T01:11:54ZThe efficacy of antipsychotics for prolonged delirium with renal dysfunction1178-2021https://doaj.org/article/9b916fb992424d63bb8cfa9ae08112702017-11-01T00:00:00Zhttps://www.dovepress.com/the-efficacy-of-antipsychotics-for-prolonged-delirium-with-renal-dysfu-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Satoko Asano, Yasuto Kunii, Hiroshi Hoshino, Yusuke Osakabe, Tetsuya Shiga, Shuntaro Itagaki, Itaru Miura, Hirooki Yabe Department of Neuropsychiatry, School of Medicine Fukushima Medical University, Fukushima, Japan Aim: Delirium is commonly encountered in daily clinical practice. To identify predictors influencing outcomes, we retrospectively examined the characteristics of inpatients with delirium who required psychiatric medication during hospitalization.Methods: We extracted all new inpatients (n=523) consulted for psychiatric symptoms at Fukushima Medical University Hospital between October 2011 and September 2013. We selected 203 inpatients with delirium diagnosed by psychiatrists. We analyzed data from 177 inpatients with delirium who received psychiatric medication. We defined an “early improvement group” in which delirium resolved in ≤3 days after starting psychiatric medication, and a “prolonged group” with delirium lasting for >3 days. Among the 83 inpatients with renal dysfunction (estimated glomerular filtration rate <60 mL/min/1.73 m2), we defined an “early improvement group with renal dysfunction” in which delirium resolved in ≤3 days after starting psychiatric medication and a “prolonged group with renal dysfunction” with delirium lasting for >3 days. We then examined differences between groups for different categorical variables.Results: Dose of antipsychotic medication at end point was significantly lower in the prolonged group with renal dysfunction than in the early improvement group with renal dysfunction.Conclusion: The results suggest that maintaining a sufficient dose of antipsychotics from an early stage may prevent prolongation of delirium even in inpatients with renal dysfunction. Keywords: antipsychotic, prolonged delirium, chronic kidney disease, pharmacokinetics Asano SKunii YHoshino HOsakabe YShiga TItagaki SMiura IYabe HDove Medical PressarticleAntipsychoticProlonged deliriumRenal dysfunctionRetrospective studyNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 13, Pp 2823-2828 (2017)
institution DOAJ
collection DOAJ
language EN
topic Antipsychotic
Prolonged delirium
Renal dysfunction
Retrospective study
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle Antipsychotic
Prolonged delirium
Renal dysfunction
Retrospective study
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Asano S
Kunii Y
Hoshino H
Osakabe Y
Shiga T
Itagaki S
Miura I
Yabe H
The efficacy of antipsychotics for prolonged delirium with renal dysfunction
description Satoko Asano, Yasuto Kunii, Hiroshi Hoshino, Yusuke Osakabe, Tetsuya Shiga, Shuntaro Itagaki, Itaru Miura, Hirooki Yabe Department of Neuropsychiatry, School of Medicine Fukushima Medical University, Fukushima, Japan Aim: Delirium is commonly encountered in daily clinical practice. To identify predictors influencing outcomes, we retrospectively examined the characteristics of inpatients with delirium who required psychiatric medication during hospitalization.Methods: We extracted all new inpatients (n=523) consulted for psychiatric symptoms at Fukushima Medical University Hospital between October 2011 and September 2013. We selected 203 inpatients with delirium diagnosed by psychiatrists. We analyzed data from 177 inpatients with delirium who received psychiatric medication. We defined an “early improvement group” in which delirium resolved in ≤3 days after starting psychiatric medication, and a “prolonged group” with delirium lasting for >3 days. Among the 83 inpatients with renal dysfunction (estimated glomerular filtration rate <60 mL/min/1.73 m2), we defined an “early improvement group with renal dysfunction” in which delirium resolved in ≤3 days after starting psychiatric medication and a “prolonged group with renal dysfunction” with delirium lasting for >3 days. We then examined differences between groups for different categorical variables.Results: Dose of antipsychotic medication at end point was significantly lower in the prolonged group with renal dysfunction than in the early improvement group with renal dysfunction.Conclusion: The results suggest that maintaining a sufficient dose of antipsychotics from an early stage may prevent prolongation of delirium even in inpatients with renal dysfunction. Keywords: antipsychotic, prolonged delirium, chronic kidney disease, pharmacokinetics 
format article
author Asano S
Kunii Y
Hoshino H
Osakabe Y
Shiga T
Itagaki S
Miura I
Yabe H
author_facet Asano S
Kunii Y
Hoshino H
Osakabe Y
Shiga T
Itagaki S
Miura I
Yabe H
author_sort Asano S
title The efficacy of antipsychotics for prolonged delirium with renal dysfunction
title_short The efficacy of antipsychotics for prolonged delirium with renal dysfunction
title_full The efficacy of antipsychotics for prolonged delirium with renal dysfunction
title_fullStr The efficacy of antipsychotics for prolonged delirium with renal dysfunction
title_full_unstemmed The efficacy of antipsychotics for prolonged delirium with renal dysfunction
title_sort efficacy of antipsychotics for prolonged delirium with renal dysfunction
publisher Dove Medical Press
publishDate 2017
url https://doaj.org/article/9b916fb992424d63bb8cfa9ae0811270
work_keys_str_mv AT asanos theefficacyofantipsychoticsforprolongeddeliriumwithrenaldysfunction
AT kuniiy theefficacyofantipsychoticsforprolongeddeliriumwithrenaldysfunction
AT hoshinoh theefficacyofantipsychoticsforprolongeddeliriumwithrenaldysfunction
AT osakabey theefficacyofantipsychoticsforprolongeddeliriumwithrenaldysfunction
AT shigat theefficacyofantipsychoticsforprolongeddeliriumwithrenaldysfunction
AT itagakis theefficacyofantipsychoticsforprolongeddeliriumwithrenaldysfunction
AT miurai theefficacyofantipsychoticsforprolongeddeliriumwithrenaldysfunction
AT yabeh theefficacyofantipsychoticsforprolongeddeliriumwithrenaldysfunction
AT asanos efficacyofantipsychoticsforprolongeddeliriumwithrenaldysfunction
AT kuniiy efficacyofantipsychoticsforprolongeddeliriumwithrenaldysfunction
AT hoshinoh efficacyofantipsychoticsforprolongeddeliriumwithrenaldysfunction
AT osakabey efficacyofantipsychoticsforprolongeddeliriumwithrenaldysfunction
AT shigat efficacyofantipsychoticsforprolongeddeliriumwithrenaldysfunction
AT itagakis efficacyofantipsychoticsforprolongeddeliriumwithrenaldysfunction
AT miurai efficacyofantipsychoticsforprolongeddeliriumwithrenaldysfunction
AT yabeh efficacyofantipsychoticsforprolongeddeliriumwithrenaldysfunction
_version_ 1718403274396139520